This present article identified five myCAFs marker genes that showed highly similar expression patterns and impact on BLCA patients’ prognosis, including ACTA2, TAGLN, MYL9, TPM1, and TPM2. The gene discussed is ACTA2; the disease is bladder transitional cell carcinoma.